Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.

Wachters JE, Schrijvers ML, Slagter-Menkema L, Mastik M, Langendijk JA, de Bock GH, Roodenburg JL, van der Laan BFAM, van der Wal JE, Schuuring E.

Laryngoscope. 2017 Sep;127(9):E301-E307. doi: 10.1002/lary.26563. Epub 2017 Mar 17.

PMID:
28304089
2.

Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer.

van der Wekken AJ, Pelgrim R, 't Hart N, Werner N, Mastik MF, Hendriks L, van der Heijden EHFM, Looijen-Salamon M, de Langen AJ, Staal-van den Brekel J, Riemersma S, van den Borne BE, Speel EJM, Dingemans AC, Hiltermann TJN, van den Berg A, Timens W, Schuuring E, Groen HJM.

Clin Cancer Res. 2017 Aug 1;23(15):4251-4258. doi: 10.1158/1078-0432.CCR-16-1631. Epub 2017 Feb 9.

3.

RAB25 expression is epigenetically downregulated in oral and oropharyngeal squamous cell carcinoma with lymph node metastasis.

Clausen MJ, Melchers LJ, Mastik MF, Slagter-Menkema L, Groen HJ, Laan BF, van Criekinge W, de Meyer T, Denil S, van der Vegt B, Wisman GB, Roodenburg JL, Schuuring E.

Epigenetics. 2016 Sep;11(9):653-663. Epub 2016 Jul 5.

4.

Genomic Aberrations in Crizotinib Resistant Lung Adenocarcinoma Samples Identified by Transcriptome Sequencing.

Saber A, van der Wekken AJ, Kok K, Terpstra MM, Bosman LJ, Mastik MF, Timens W, Schuuring E, Hiltermann TJ, Groen HJ, van den Berg A.

PLoS One. 2016 Apr 5;11(4):e0153065. doi: 10.1371/journal.pone.0153065. eCollection 2016.

5.

Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma.

Clausen MJ, Melchers LJ, Mastik MF, Slagter-Menkema L, Groen HJ, van der Laan BF, van Criekinge W, de Meyer T, Denil S, Wisman GB, Roodenburg JL, Schuuring E.

Genes Chromosomes Cancer. 2016 Jan;55(1):45-59. doi: 10.1002/gcc.22310. Epub 2015 Sep 22.

PMID:
26391330
6.

Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinoma.

Melchers LJ, Clausen MJ, Mastik MF, Slagter-Menkema L, van der Wal JE, Wisman GB, Roodenburg JL, Schuuring E.

Epigenetics. 2015;10(9):850-60. doi: 10.1080/15592294.2015.1075689.

7.

Detection of HPV-associated oropharyngeal tumours in a 16-year cohort: more than meets the eye.

Melchers LJ, Mastik MF, Samaniego Cameron B, van Dijk BA, de Bock GH, van der Laan BF, van der Vegt B, Speel EJ, Roodenburg JL, Witjes MJ, Schuuring E.

Br J Cancer. 2015 Apr 14;112(8):1349-57. doi: 10.1038/bjc.2015.99. Epub 2015 Mar 17.

8.

Head and neck squamous cell carcinomas do not express EGFRvIII.

Melchers LJ, Clausen MJ, Mastik MF, Slagter-Menkema L, Langendijk JA, van der Laan BF, van der Wal JE, van der Vegt B, Roodenburg JL, Schuuring E.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):454-62. doi: 10.1016/j.ijrobp.2014.06.035.

PMID:
25304797
9.

Prognostic significance of HIF-1a, CA-IX, and OPN in T1-T2 laryngeal carcinoma treated with radiotherapy.

Wachters JE, Schrijvers ML, Slagter-Menkema L, Mastik M, de Bock GH, Langendijk JA, Kluin PM, Schuuring E, van der Laan BF, van der Wal JE.

Laryngoscope. 2013 Sep;123(9):2154-60.

PMID:
24167820
10.

Lack of claudin-7 is a strong predictor of regional recurrence in oral and oropharyngeal squamous cell carcinoma.

Melchers LJ, Bruine de Bruin L, Schnell U, Slagter-Menkema L, Mastik MF, de Bock GH, van Dijk BA, Giepmans BN, van der Laan BF, van der Wal JE, Roodenburg JL, Schuuring E.

Oral Oncol. 2013 Oct;49(10):998-1005. doi: 10.1016/j.oraloncology.2013.07.008. Epub 2013 Aug 13.

PMID:
23953778
11.

FADD expression is associated with regional and distant metastasis in squamous cell carcinoma of the head and neck.

Pattje WJ, Melchers LJ, Slagter-Menkema L, Mastik MF, Schrijvers ML, Gibcus JH, Kluin PM, Hoegen-Chouvalova O, van der Laan BF, Roodenburg JL, van der Wal JE, Schuuring E, Langendijk JA.

Histopathology. 2013 Aug;63(2):263-70. doi: 10.1111/his.12174. Epub 2013 Jun 13.

PMID:
23763459
12.

FADD expression as a prognosticator in early-stage glottic squamous cell carcinoma of the larynx treated primarily with radiotherapy.

Schrijvers ML, Pattje WJ, Slagter-Menkema L, Mastik MF, Gibcus JH, Langendijk JA, van der Wal JE, van der Laan BF, Schuuring E.

Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1220-6. doi: 10.1016/j.ijrobp.2011.09.060. Epub 2011 Dec 28.

13.

The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer.

Pattje WJ, Schuuring E, Mastik MF, Slagter-Menkema L, Schrijvers ML, Alessi S, van der Laan BF, Roodenburg JL, Langendijk JA, van der Wal JE.

Br J Cancer. 2010 Jun 8;102(12):1778-85. doi: 10.1038/sj.bjc.6605707. Epub 2010 May 25.

14.

Radiotherapy in laryngeal carcinoma: can a panel of 13 markers predict response?

Wildeman MA, Gibcus JH, Hauptmann M, Begg AC, van Velthuysen ML, Hoebers FJ, Mastik MF, Schuuring E, van der Wal JE, van den Brekel MW.

Laryngoscope. 2009 Feb;119(2):316-22. doi: 10.1002/lary.20069.

PMID:
19160427
15.

Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.

Schrijvers ML, van der Laan BF, de Bock GH, Pattje WJ, Mastik MF, Menkema L, Langendijk JA, Kluin PM, Schuuring E, van der Wal JE.

Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):161-9. doi: 10.1016/j.ijrobp.2008.05.025.

PMID:
18722267
16.

The relation between histological, tumor-biological and clinical parameters in deep and superficial leiomyosarcoma and leiomyoma.

Pijpe J, Broers GH, Plaat BE, Hundeiker M, Otto F, Mastik MF, Hoekstra HJ, van der Graaf WT, Berg Ev, Molenaar WM.

Sarcoma. 2002;6(3):105-10. doi: 10.1080/1357714021000065404.

17.

Cortactin expression predicts poor survival in laryngeal carcinoma.

Gibcus JH, Mastik MF, Menkema L, de Bock GH, Kluin PM, Schuuring E, van der Wal JE.

Br J Cancer. 2008 Mar 11;98(5):950-5. doi: 10.1038/sj.bjc.6604246. Epub 2008 Feb 12.

18.

Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer.

Gibcus JH, Menkema L, Mastik MF, Hermsen MA, de Bock GH, van Velthuysen ML, Takes RP, Kok K, Alvarez Marcos CA, van der Laan BF, van den Brekel MW, Langendijk JA, Kluin PM, van der Wal JE, Schuuring E.

Clin Cancer Res. 2007 Nov 1;13(21):6257-66.

19.

High-resolution mapping identifies a commonly amplified 11q13.3 region containing multiple genes flanked by segmental duplications.

Gibcus JH, Kok K, Menkema L, Hermsen MA, Mastik M, Kluin PM, van der Wal JE, Schuuring E.

Hum Genet. 2007 Apr;121(2):187-201. Epub 2006 Dec 15.

PMID:
17171571
20.

Identification of chromosomal copy number changes associated with transformation of follicular lymphoma to diffuse large B-cell lymphoma.

Boonstra R, Bosga-Bouwer A, Mastik M, Haralambieva E, Conradie J, van den Berg E, van den Berg A, Poppema S.

Hum Pathol. 2003 Sep;34(9):915-23.

PMID:
14562288
21.

Analysis of chromosomal copy number changes and oncoprotein expression in primary central nervous system lymphomas: frequent loss of chromosome arm 6q.

Boonstra R, Koning A, Mastik M, van den Berg A, Poppema S.

Virchows Arch. 2003 Aug;443(2):164-9. Epub 2003 Jun 12.

PMID:
12802586
22.
23.

Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins.

Plaat BE, Hollema H, Molenaar WM, Torn Broers GH, Pijpe J, Mastik MF, Hoekstra HJ, van den Berg E, Scheper RJ, van der Graaf WT.

J Clin Oncol. 2000 Sep 15;18(18):3211-20.

PMID:
10986053
24.

The 16p11 breakpoint in myxoid liposarcomas might affect the expression of the LRP gene on 16p11.2 encoding the multidrug resistance associated major vault protein.

Plaat BE, Molenaar WM, Sagrudny J, Bohle RM, Mastik MF, Hoekstra HJ, Van der Graaf WT, Hollema H, van den Berg E.

Eur J Clin Invest. 2000 May;30(5):447-53.

PMID:
10809905
25.

Computer-assisted cytogenetic analysis of 51 malignant peripheral-nerve-sheath tumors: sporadic vs. neurofibromatosis-type-1-associated malignant schwannomas.

Plaat BE, Molenaar WM, Mastik MF, Hoekstra HJ, te Meerman GJ, van den Berg E.

Int J Cancer. 1999 Oct 8;83(2):171-8.

27.
28.

Translocation (11;22)(q24;q12) in a small cell tumor of the thigh in a 2-year-old boy: immunohistology, cytogenetics, molecular genetics, and review of the literature.

Mastik MF, Molenaar WM, Plaat BE, de Graaf SS, Hogendoorn PC, van der Hout AH, van den Berg E.

Hum Pathol. 1999 Mar;30(3):352-5. Review.

PMID:
10088556
29.

Proliferative activity in human brain tumors: comparison of histopathology and L-[1-(11)C]tyrosine PET.

de Wolde H, Pruim J, Mastik MF, Koudstaal J, Molenaar WM.

J Nucl Med. 1997 Sep;38(9):1369-74.

Supplemental Content

Loading ...
Support Center